title: RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma.
abstract: RARRES3 is a retinoid-inducible class II tumour-suppressor gene. This study analysed the expression of RARRES3 protein in normal, adenoma and carcinoma tissues of the colorectum and its correlation with tumour differentiation. The expression of RARRES3 protein in 151 paraffin-embedded colorectal tissues (11 distal normal mucosa, 20 adenoma and 120 colorectal adenocarcinoma) was determined by immunohistochemistry. RARRES3 protein was expressed in all 11 distal normal, 120 adjacent normal and 20 adenoma tissues. In distal normal tissues, RARRES3 protein was expressed at the highest levels in differentiated mucosal epithelial cells. Among 120 carcinoma tissues, RARRES3 protein was detected in 97.6% (40 out of 41), 79.4% (54 out of 68) and 17.3% (three out of 11) of well-, moderately and poorly differentiated tumours, respectively. The expression of RARRES3 protein was positively correlated to tumour differentiation (test for trend, P<0.0001). Also, levels of RARRES3 protein were found to be higher in the normal tissues adjacent to 14.6% (six out of 41), 51.5% (35 out of 68), and 90.1% (10 out of 11) of well-, moderately and poorly differentiated tumours, respectively. The decreases in tumour differentiation and RARRES3 expression were significantly correlated compared to the adjacent normal tissues (test for trend, P<0.0001). The prognostic implication of RARRES3 protein expression was studied in 107 tumour, and no statistical difference in survival was observed. The expression of RARRES3 protein was positively correlated to cellular differentiation of normal and adenocarcinoma tissues of the colorectum, which supports the role of RARRES3 in normal and malignant epithelial differentiation of colorectum. RARRES3 expression was decreased only in carcinoma tissue, which suggests that altered RARRES3 expression occurs late in colorectal carcinogenesis.
authors.affiliation: Department of Internal Medicine, Tri-Service General Hospital, 325 Chengung Rd, Sec. 2, Taipei, Taiwan 114, Republic of China. jsy@ndmctwgh.edu.tw
authors.forename: R-Y
authors.initials: RY
authors.lastname: Shyu
authors.forename: S-Y
authors.initials: SY
authors.lastname: Jiang
authors.forename: J-M
authors.initials: JM
authors.lastname: Chou
authors.forename: Y-L
authors.initials: YL
authors.lastname: Shih
authors.forename: M-S
authors.initials: MS
authors.lastname: Lee
authors.forename: J-C
authors.initials: JC
authors.lastname: Yu
authors.forename: P-C
authors.initials: PC
authors.lastname: Chao
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Hsu
authors.forename: S-W
authors.initials: SW
authors.lastname: Jao
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology*; D000236:Adenoma / Q000235:genetics* / Q000473:pathology*; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000473:pathology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018168:Receptors, Retinoic Acid / Q000096:biosynthesis*; D013534:Survival
chemical_list: C437968:PLAAT4 protein, human; D018168:Receptors, Retinoic Acid